Reproductive Sciences-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2026-03-11 zhufufriend 来自山东省

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤;生信
经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人

29 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2024-09-03 ms2000000922500034 来自山东省

8.22投稿，到现在一直是Editor Assigned，这是要被拒吗

115 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2014-12-04 lzt1988

审稿速度:1.0 | 投稿命中率:50.0
经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！

417 8 举报

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2025-02-11 ms9000001079349839 来自山东省

现在收生信+实验的文章吗

87 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2024-07-02 ms4000000480569699 来自陕西省

偏重的研究方向：生殖医学
经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！

216 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2021-07-09 ms6000001352468085

2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了

201 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2022-03-25 pmzhangjie

请问大家irb approval怎么搞的啊

188 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2023-11-13 ms7000000322607475 来自甘肃省

审稿速度:1.0
偏重的研究方向：生殖医学
经验分享：有大佬知道 Change authorship form在哪儿嘛？

202 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2021-12-23 ms3000002068420902

偏重的研究方向：生物信息学;围产医学;生殖医学
经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神

184 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2303179, encodeId=a3af23031e931, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤;生信 经验分享：总体来说比较容易命中，就是投稿周期太长，修改意见很简单，就是慢，历时整1年，着急用论文的人不建议投，特别消磨人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0801687349, createdName=zhufufriend, createdTime=Wed Mar 11 08:37:44 CST 2026, time=2026-03-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2223836, encodeId=105b222383613, content=8.22投稿，到现在一直是Editor Assigned，这是要被拒吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c3b9416313, createdName=ms2000000922500034, createdTime=Tue Sep 03 13:40:14 CST 2024, time=2024-09-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=508154, encodeId=e980508154ad, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：审稿速度快，意见中肯，我是刚好1个月审稿，要求小修，认真回复后，1个周后接受。本人第一篇SCI，颇感兴奋，愿大家一起进步！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=417, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=31b3107545, createdName=lzt1988, createdTime=Thu Dec 04 19:07:00 CST 2014, time=2014-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2251476, encodeId=d48022514e698, content=现在收生信+实验的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aad68577664, createdName=ms9000001079349839, createdTime=Tue Feb 11 15:37:56 CST 2025, time=2025-02-11, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2212786, encodeId=395f2212e86c9, content=偏重的研究方向：生殖医学 经验分享：2024.1.27投稿，两天立即送审了，中间找了2.3个月审稿人哈哈哈，5.20一审意见返回，大修，修了10天左右送回去了，6.25接收，第二篇sci，共勉！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66548632914, createdName=ms4000000480569699, createdTime=Tue Jul 02 14:33:27 CST 2024, time=2024-07-02, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=998056, encodeId=d8f0998056a3, content=2020年10月31号投稿，2021年1月14日返修，2月25日修回，2月27日显示送外审，到现在状态也没变化，时间也没变化，有没有类似情况的朋友？已经4个多月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ceb5420687, createdName=ms6000001352468085, createdTime=Fri Jul 09 20:11:44 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205846, encodeId=869e1205846dc, content=请问大家irb approval怎么搞的啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/GVenxYicdvic8y0S8u0eCicFMiaY4MhYKianWnHAOEhmrUuIG95l4TY9VHliaG0SHOtNeXQia1WYGhhYMSzHcDlaz4WBA/132, createdBy=e3105157968, createdName=pmzhangjie, createdTime=Fri Mar 25 13:42:05 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2168342, encodeId=0a6c2168342a4, content=审稿速度:1.0 偏重的研究方向：生殖医学 经验分享：有大佬知道 Change authorship form在哪儿嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2c38649666, createdName=ms7000000322607475, createdTime=Mon Nov 13 21:54:09 CST 2023, time=2023-11-13, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1083380, encodeId=813c108338041, content=偏重的研究方向：生物信息学;围产医学;生殖医学 经验分享：请问上传伦理审查的文件在哪里找，提交需要IRB approval，是自己写完找单位盖章吗，求各位大神 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=996d5652385, createdName=ms3000002068420902, createdTime=Thu Dec 23 00:22:15 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569900, encodeId=32645699002b, content=online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/08/20/848cb2649bb2ba3563871a6dd0e8c5e7.jpg, createdBy=45362264868, createdName=打豆豆d d d, createdTime=Mon Apr 22 00:00:00 CST 2019, time=2019-04-22, status=1, ipAttribution=)]

2019-04-22 打豆豆d d d

online快一年了，还没有正式出版没有卷和期号无法进行文献检索啊

230 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务